Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Current Oncology Reports|June 22, 2020
Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a ReviewJenica N UpshawGland Surgery|September 4, 2018
Cardio-oncology: protecting the heart from curative breast cancer treatmentJenica N UpshawCurrent Treatment Options in Oncology|August 9, 2020
The Role of Biomarkers to Evaluate CardiotoxicityJenica N UpshawHeart Failure Clinics|June 19, 2022
Cardioprotection of High-Risk IndividualsJenica N Upshaw, Sharanya Mohanty, Akash RastogiCurrent Medical Research and Opinion|September 16, 2021
In-hospital mortality, length of stay and hospital costs for hospitalized breast cancer patients with comorbid heart failure in the USAChanhyun Park, Sun-Kyeong Park, Jenica N Upshaw, et al.The American Journal of Medicine|December 29, 2017
Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk ModelJenica N Upshaw, David van Klaveren, Marvin A Konstam, et al.Hematology. American Society of Hematology. Education Program|December 9, 2023
Hodgkin lymphoma treatment for older persons in the modern eraAndrew M Evens, Marshall McKenna, Yun Kyoung Ryu Tiger, et al.JACC. Cardiooncology|September 15, 2025
Cardiovascular and Oncologic Considerations in Adult Hodgkin Lymphoma: JACC: CardioOncology State-of the-Art ReviewHari S Raman, Joshua Mitchell, Anju Nohria, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 20, 2015
Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device ThrombosisJenica N Upshaw, Michael S Kiernan, Kevin J Morine, et al.JACC. Case Reports|July 11, 2025
Permissive Cardiotoxicity and Determination of Anthracycline Risk With Previous Anthracycline ExposureRichard J Travers, Nicholas Camarda, Iris Z Jaffe, et al.Pageof 5